- Home
- OGS vs XENE Comparison
OGS vs XENE Comparison
Compare OGS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGS | XENE |
|---|---|---|
| Founded | 1906 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OGS | XENE |
|---|---|---|
| Price | $78.20 | $35.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 19 |
| Target Price | ★ $86.28 | $72.43 |
| AVG Volume (30 Days) | 558.7K | ★ 1.7M |
| Earning Date | 11-02-2026 | 11-06-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $2,578,005,000.00 | $311,000.00 |
| Revenue This Year | $2.31 | N/A |
| Revenue Next Year | $3.89 | $2,045.70 |
| P/E Ratio | $28.14 | ★ N/A |
| Revenue Growth | ★ 42.54 | N/A |
| 52 Week Low | $70.37 | $33.38 |
| 52 Week High | $90.78 | $72.66 |
Technical Indicators
Market Signals| Indicator | OGS | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 65.51 | 34.04 |
| Support Level | $75.94 | $33.38 |
| Resistance Level | $79.79 | $43.68 |
| Average True Range (ATR) | 1.35 | 1.24 |
| MACD | 0.74 | 0.91 |
| Stochastic Oscillator | 92.35 | 48.30 |
Price Performance
Historical ComparisonAbout OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.